Randomized Controlled Trial to determine if the outcomes of sclerotherapy of the ulcer bed alone differ from a combination of ablation and sclerotherapy injections.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Baseline Ulcer Healing Rate
Timeframe: Start of Treatment (Baseline)
3 Month Ulcer Healing Rate Change
Timeframe: 3 months following start of treatment
6 Month Ulcer Healing Rate Change
Timeframe: 6 months following start of treatment
Baseline Ulcer Size (Length)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Width)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Surface Area)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Depth)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Volume)
Timeframe: Start of Treatment (Baseline)
3 Month Ulcer Size (Length)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Width)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Surface Area)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Depth)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Volume)
Timeframe: 3 months following start of treatment
6 Month Ulcer Size (Length)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Width)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Surface Area)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Depth)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Volume)
Timeframe: 6 months following start of treatment
Baseline Clinical Evaluation
Timeframe: Start of Treatment (Baseline)
3 Month Clinical Evaluation; Change Assessment
Timeframe: 3 months following start of treatment
6 Month Clinical Evaluation; Change Assessment
Timeframe: 6 months following start of treatment
Baseline_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym)
Timeframe: Start of Treatment (Baseline)
3 Month_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym); Change Assessment
Timeframe: 3 months following start of treatment
6 Month_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym); Change Assessment
Timeframe: 6 months following start of treatment
Baseline_Venous Clinical Severity Score (VCSS)
Timeframe: Start of Treatment (Baseline)
3 Month_Venous Clinical Severity Score (VCSS); Change Assessment)
Timeframe: 3 months following start of treatment
6 Month_Venous Clinical Severity Score (VCSS); Change Assessment
Timeframe: 6 months following start of treatment